Irinotecan and Docetaxel With or Without Cetuximab in Treating Patients With Metastatic Pancreatic Cancer
Clinical trial NCT00042939 · COMPLETED
Trial details
- NCT number
- NCT00042939
- Sponsor
- Eastern Cooperative Oncology Group
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-12-09
- Primary completion
- 2009-06-01
- Enrollment
- 94
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.